Cellectis Sa Stock Market Value
| CLLS Stock | USD 3.90 0.09 2.26% |
| Symbol | Cellectis |
Is there potential for Biotechnology market expansion? Will Cellectis introduce new products? Factors like these will boost the valuation of Cellectis. Projected growth potential of Cellectis fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Cellectis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cellectis SA is measured differently than its book value, which is the value of Cellectis that is recorded on the company's balance sheet. Investors also form their own opinion of Cellectis' value that differs from its market value or its book value, called intrinsic value, which is Cellectis' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Cellectis' market value can be influenced by many factors that don't directly affect Cellectis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Cellectis' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cellectis should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Cellectis' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cellectis 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cellectis' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cellectis.
| 11/23/2025 |
| 02/21/2026 |
If you would invest 0.00 in Cellectis on November 23, 2025 and sell it all today you would earn a total of 0.00 from holding Cellectis SA or generate 0.0% return on investment in Cellectis over 90 days. Cellectis is related to or competes with Alto Neuroscience, AC Immune, Aldeyra, Amarin PLC, Alpha Tau, Larimar Therapeutics, and Silence Therapeutics. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cell... More
Cellectis Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cellectis' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cellectis SA upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 27.0 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 6.33 |
Cellectis Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cellectis' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cellectis' standard deviation. In reality, there are many statistical measures that can use Cellectis historical prices to predict the future Cellectis' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (0.84) | |||
| Treynor Ratio | 2.91 |
Cellectis February 21, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | 2.92 | |||
| Mean Deviation | 3.39 | |||
| Coefficient Of Variation | (1,098) | |||
| Standard Deviation | 4.54 | |||
| Variance | 20.63 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (0.84) | |||
| Treynor Ratio | 2.91 | |||
| Maximum Drawdown | 27.0 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 6.33 | |||
| Skewness | (0.37) | |||
| Kurtosis | 1.42 |
Cellectis SA Backtested Returns
Cellectis SA secures Sharpe Ratio (or Efficiency) of -0.091, which signifies that the company had a -0.091 % return per unit of risk over the last 3 months. Cellectis SA exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cellectis' Risk Adjusted Performance of (0.06), mean deviation of 3.39, and Standard Deviation of 4.54 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.15, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Cellectis are expected to decrease at a much lower rate. During the bear market, Cellectis is likely to outperform the market. At this point, Cellectis SA has a negative expected return of -0.41%. Please make sure to confirm Cellectis' value at risk, as well as the relationship between the daily balance of power and price action indicator , to decide if Cellectis SA performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.39 |
Below average predictability
Cellectis SA has below average predictability. Overlapping area represents the amount of predictability between Cellectis time series from 23rd of November 2025 to 7th of January 2026 and 7th of January 2026 to 21st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cellectis SA price movement. The serial correlation of 0.39 indicates that just about 39.0% of current Cellectis price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.39 | |
| Spearman Rank Test | 0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.09 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cellectis Stock Analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.